KEISHA-ANN GORDON-PRIMUS: Open Payments
NPI 1093196537 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,099 in 9 payments from 8 companies in 2025. Trend: 2023 $1,024 · 2024 $794 · 2025 $1,099
Food & beverage: $1,099
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $259 |
| Edwards Lifesciences Corporation | 1 | $154 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $117 |
| AstraZeneca Pharmaceuticals LP | 1 | $117 |
| Novo Nordisk Inc | 1 | $109 |
| COLOPLAST CORP | 1 | $94 |
Products named: Livdelzi, Epclusa, INGREZZA, VRAYLAR, Auvelity, AIRSUPRA, Titan.
Industry payments across FL — which companies pay providers there.
